Department of Psychiatry, Massachusetts General Hospital, 100 Cambridge St., Suite 1600, Boston, MA, 02114, USA.
Health Promotion and Resiliency Intervention Research (HPRIR) Program, Massachusetts General Hospital, Boston, MA, USA.
Support Care Cancer. 2023 Oct 6;31(10):616. doi: 10.1007/s00520-023-08062-1.
Cancer "curvivors" (completed initial curative intent treatment with surgery, radiation, chemotherapy, and/or other novel therapies) and "metavivors" (living with metastatic or chronic, incurable cancer) experience unique stressors, but it remains unknown whether these differences impact benefits from mind-body interventions. This study explored differences between curvivors and metavivors in distress (depression, anxiety, worry) and resiliency changes over the course of an 8-week group program, based in mind-body stress reduction, cognitive-behavioral therapy (CBT), and positive psychology.
From 2017-2021, 192 cancer survivors (83% curvivors; 17% metavivors) completed optional online surveys of resiliency (CES) and distress (PHQ-8, GAD-7, PSWQ-3) pre- and post- participation in an established clinical program. Mixed effect regression models explored curvivor-metavivor differences at baseline and in pre-post change.
Compared to curvivors, metavivors began the program with significantly more resilient health behaviors (B = 0.99, 95% CI[0.12, 1.86], p = .03) and less depression (B = -2.42, 95%CI[-4.73, -0.12], p = .04), with no other significant differences. Curvivors experienced significantly greater reductions in depression (curvivor-metavivor difference in strength of change = 2.12, 95% CI [0.39, 3.83], p = .02) over the course of the program, with no other significant differences. Neither virtual delivery modality nor proportion of sessions attended significantly moderated strength of resiliency or distress change.
Metavivors entering this mind-body program had relatively higher well-being than did curvivors, and both groups experienced statistically comparable change in all domains other than depression. Resiliency programming may thus benefit a variety of cancer survivors, including those living with incurable cancer.
癌症“幸存者”(接受过手术、放疗、化疗和/或其他新疗法的初始治愈性治疗)和“代谢幸存者”(患有转移性或慢性、无法治愈的癌症)经历着独特的压力源,但目前尚不清楚这些差异是否会影响身心干预的益处。本研究探讨了基于身心减压、认知行为疗法(CBT)和积极心理学的 8 周小组项目中,幸存者和代谢幸存者在困扰(抑郁、焦虑、担忧)和复原力变化方面的差异。
2017 年至 2021 年,192 名癌症幸存者(83%为幸存者;17%为代谢幸存者)完成了关于复原力(CES)和困扰(PHQ-8、GAD-7、PSWQ-3)的在线调查,这些调查在参加既定临床项目之前和之后进行。混合效应回归模型探讨了基线和预-后变化中幸存者-代谢幸存者的差异。
与幸存者相比,代谢幸存者在开始该项目时具有更健康的复原力行为(B=0.99,95%CI[0.12,1.86],p=0.03)和更少的抑郁(B=-2.42,95%CI[-4.73,-0.12],p=0.04),但没有其他显著差异。在项目过程中,幸存者的抑郁程度显著降低(幸存者-代谢幸存者变化的强度差异=2.12,95%CI[0.39,3.83],p=0.02),但没有其他显著差异。虚拟交付模式或参加课程的比例都没有显著调节复原力或困扰变化的强度。
进入该身心项目的代谢幸存者的幸福感相对较高,与幸存者相比,所有领域除抑郁外,两组的变化都具有统计学可比性。因此,复原力计划可能使各种癌症幸存者受益,包括那些患有无法治愈的癌症的幸存者。